Aspiriant LLC Has $311,000 Stock Position in MetLife, Inc. $MET

Aspiriant LLC boosted its position in MetLife, Inc. (NYSE:MET) by 15.9% in the 2nd quarter, HoldingsChannel reports. The firm owned 3,866 shares of the financial services provider’s stock after acquiring an additional 530 shares during the period. Aspiriant LLC’s holdings in MetLife were worth $311,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Csenge Advisory Group lifted its holdings in MetLife by 1.0% during the 1st quarter. Csenge Advisory Group now owns 13,647 shares of the financial services provider’s stock worth $1,096,000 after purchasing an additional 131 shares during the last quarter. Delta Investment Management LLC boosted its position in shares of MetLife by 0.9% in the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock valued at $1,145,000 after acquiring an additional 133 shares during the period. Ignite Planners LLC increased its position in MetLife by 2.2% during the second quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock worth $491,000 after acquiring an additional 136 shares during the period. Glenview Trust co raised its stake in MetLife by 0.4% in the 1st quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock worth $3,078,000 after purchasing an additional 141 shares in the last quarter. Finally, My Legacy Advisors LLC grew its position in shares of MetLife by 1.2% during the 2nd quarter. My Legacy Advisors LLC now owns 14,000 shares of the financial services provider’s stock worth $1,097,000 after purchasing an additional 164 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Weiss Ratings reissued a “buy (b)” rating on shares of MetLife in a report on Wednesday, October 8th. Wolfe Research upgraded shares of MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. Piper Sandler downgraded shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price target for the company. in a report on Friday, September 19th. Jefferies Financial Group lifted their price objective on shares of MetLife from $100.00 to $103.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Finally, Cowen restated a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.18.

MetLife Price Performance

MET stock opened at $78.55 on Friday. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $89.05. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $52.24 billion, a price-to-earnings ratio of 13.31, a P/E/G ratio of 0.71 and a beta of 0.86. The company has a 50 day simple moving average of $80.20 and a 200 day simple moving average of $78.08.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $18.58 billion. During the same period in the previous year, the firm posted $2.28 EPS. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. Research analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s dividend payout ratio (DPR) is presently 38.47%.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.